FDA Phase / Business Partnership / Funding / Company Listing Change / /
Facility
Diaxonhit headquarters / Kremlin Bicêtre Hospital / Bordeaux University / French National Institute / Southern Paris University / /
IndustryTerm
therapeutic and diagnostic solutions / care of HIV / diagnostic products / biopharmaceutical / treatment of HIV / commercialization network / /
MarketIndex
NYSE Alternext OSEO innovation / /
MedicalCondition
HIV / AIDS epidemic / HIV infections / cancer / disease / infectious and chronic diseases / chronic inflammatory diseases / AIDS / infectious diseases / HIV/AIDS / infection / /
MedicalTreatment
vaccine therapy / immunotherapy / /
Organization
Bordeaux University / World Health Organization / Southern Paris University / French National Agency for Research / Ile-of-France Center for Innovation / Kremlin Bicêtre Hospital / French National Institute for Medical Research / Institut de Vei / Ministry of Higher Education and Research / /
Person
Jennifer Jullia / Loïc Maurel / Hervé Duchesne de Lamotte / Alexandre Commerot / / /
Position
project leader / fully integrated leader / President / CFO / President of Management Board / /
PRESS RELEASE Diaxonhit receives financing from Bpifrance for the development of a companion diagnostic for a therapeutic vaccine against AIDS •